Mineo Chrysa
Insider CIK 1575644 · RCPT VP, Corporate Development · CDTX Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| CDTX Cidara Therapeutics, Inc. | D To issuer deriv | 2026-01-07 | 2026-01-07 | 550 | — | $0 | 0 | SEC↗ |
| CDTX Cidara Therapeutics, Inc. | D To issuer deriv | 2026-01-07 | 2026-01-07 | 875 | — | $0 | 0 | SEC↗ |
| CDTX Cidara Therapeutics, Inc. | D To issuer deriv | 2026-01-07 | 2026-01-07 | 1,400 | — | $0 | 0 | SEC↗ |
| CDTX Cidara Therapeutics, Inc. | D To issuer deriv | 2026-01-07 | 2026-01-07 | 1,000 | — | $0 | 0 | SEC↗ |
| CDTX Cidara Therapeutics, Inc. | D To issuer deriv | 2026-01-07 | 2026-01-07 | 2,125 | — | $0 | 0 | SEC↗ |
| CDTX Cidara Therapeutics, Inc. | D To issuer deriv | 2026-01-07 | 2026-01-07 | 11,100 | — | $0 | 0 | SEC↗ |
| CDTX Cidara Therapeutics, Inc. | D To issuer deriv | 2026-01-07 | 2026-01-07 | 19,000 | — | $0 | 0 | SEC↗ |
| CDTX Cidara Therapeutics, Inc. | D To issuer deriv | 2026-01-07 | 2026-01-07 | 550 | — | $0 | 0 | SEC↗ |
| CDTX Cidara Therapeutics, Inc. | D To issuer deriv | 2026-01-07 | 2026-01-07 | 875 | — | $0 | 0 | SEC↗ |
| CDTX Cidara Therapeutics, Inc. | D To issuer deriv | 2026-01-07 | 2026-01-07 | 2,125 | — | $0 | 0 | SEC↗ |
| CDTX Cidara Therapeutics, Inc. | D To issuer | 2026-01-07 | 2026-01-07 | 3,320 | $221.50 | $735.4K | 0 | SEC↗ |
| CDTX Cidara Therapeutics, Inc. | A Award deriv | 2025-06-18 | 2025-06-18 | 11,100 | — | $0 | 11,100 | SEC↗ |
| CDTX Cidara Therapeutics, Inc. | P Buy | 2025-06-03 | 2025-06-04 | 1,050 | $23.44 | $24.6K | 3,320 | SEC↗ |
| CDTX Cidara Therapeutics, Inc. | P Buy | 2025-06-02 | 2025-06-04 | 2,270 | $21.71 | $49.3K | 2,270 | SEC↗ |
| CDTX Cidara Therapeutics, Inc. | A Award deriv | 2024-12-17 | 2024-12-19 | 19,000 | — | $0 | 19,000 | SEC↗ |
| CDTX Cidara Therapeutics, Inc. | A Award deriv | 2024-07-18 | 2024-07-19 | 2,125 | — | $0 | 2,125 | SEC↗ |
| CDTX Cidara Therapeutics, Inc. | A Award deriv | 2023-06-22 | 2023-06-23 | 42,500 | — | $0 | 42,500 | SEC↗ |
| CDTX Cidara Therapeutics, Inc. | A Award deriv | 2022-06-22 | 2022-06-24 | 28,000 | — | $0 | 28,000 | SEC↗ |
| CDTX Cidara Therapeutics, Inc. | A Award deriv | 2021-06-23 | 2021-06-24 | 17,500 | — | $0 | 17,500 | SEC↗ |
| CDTX Cidara Therapeutics, Inc. | A Award deriv | 2020-06-25 | 2020-06-25 | 17,500 | — | $0 | 17,500 | SEC↗ |
| CDTX Cidara Therapeutics, Inc. | A Award deriv | 2019-06-17 | 2019-06-27 | 11,000 | — | $0 | 11,000 | SEC↗ |
| CDTX Cidara Therapeutics, Inc. | A Award deriv | 2018-06-13 | 2018-06-15 | 11,000 | — | $0 | 11,000 | SEC↗ |
| CDTX Cidara Therapeutics, Inc. | A Award deriv | 2018-03-01 | 2018-03-01 | 20,000 | — | $0 | 20,000 | SEC↗ |
| RCPT Receptos, Inc. | D To issuer deriv | 2015-08-27 | 2015-08-27 | 13,333 | $223.90 | $2.99M | 0 | SEC↗ |
| RCPT Receptos, Inc. | D To issuer deriv | 2015-08-27 | 2015-08-27 | 30,000 | $213.23 | $6.40M | 0 | SEC↗ |
| RCPT Receptos, Inc. | D To issuer deriv | 2015-08-27 | 2015-08-27 | 20,000 | $203.63 | $4.07M | 0 | SEC↗ |
| RCPT Receptos, Inc. | D To issuer deriv | 2015-08-27 | 2015-08-27 | 36,945 | $190.49 | $7.04M | 0 | SEC↗ |
| RCPT Receptos, Inc. | D To issuer | 2015-08-27 | 2015-08-27 | 7,000 | — | $0 | 0 | SEC↗ |
| RCPT Receptos, Inc. | U Tender | 2015-08-25 | 2015-08-27 | 104,692 | — | $0 | 7,000 | SEC↗ |
| RCPT Receptos, Inc. | A Award | 2015-04-01 | 2015-04-03 | 7,000 | — | $0 | 111,692 | SEC↗ |
| RCPT Receptos, Inc. | S Sale | 2014-11-10 | 2014-11-12 | 30,000 | $109.73 | $3.29M | 104,692 | SEC↗ |
| RCPT Receptos, Inc. | A Award deriv | 2014-04-03 | 2014-04-07 | 36,945 | — | $0 | 36,945 | SEC↗ |
| RCPT Receptos, Inc. | A Award deriv | 2013-12-23 | 2013-12-26 | 20,000 | — | $0 | 20,000 | SEC↗ |
| RCPT Receptos, Inc. | A Award deriv | 2013-07-17 | 2013-07-19 | 30,000 | — | $0 | 30,000 | SEC↗ |
| RCPT Receptos, Inc. | C Conversion deriv | 2013-05-14 | 2013-05-14 | 65,267 | — | $0 | 0 | SEC↗ |
| RCPT Receptos, Inc. | C Conversion | 2013-05-14 | 2013-05-14 | 8,702 | $5.25 | $45.7K | 134,692 | SEC↗ |